RCL Joins the EU-Funded TEN4CARE Project

We are thrilled to announce our participation in TEN4CARE, a groundbreaking €7.9M European Union Horizon Europe initiative aimed at revolutionising tendon injury treatment.

Alongside 15 international partners, we are contributing to the development of a personalized, 4D nanocomposite fibrous hydrogel. This cutting-edge medical device uses shape memory and electromagnetic sensitivity to enable minimally invasive, regenerative tendon repair.

By combining advanced materials science with targeted drug delivery, TEN4CARE will accelerate recovery and improve quality of life for millions of patients. Stay tuned for updates on our progress!

Previous
Previous

RCL at the Royal Society Summer Science Exhibition 2026

Next
Next

Resonant Circuits Limited Advances Cancer Therapy with Quantum Thermometry